ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7
Zimmer Biomet wins early PMDA approval in Japan for its iTaperloc Complete and iG7 Hip System with Iodine Technology.
Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum
HOLX's Interventional Breast business hits $100M as Endomag products boost recurring revenues and margins.
Robotics and MedSurg Drive Stryker Growth Amid Margin Pressures
SYK posts 11% sales growth and EPS beat for Q2, driven by Mako robotics and MedSurg strength, but faces cost and margin headwinds.
ISRG SP Platform's Expansion in Korea and Europe Gains Traction
Intuitive Surgical's SP platform gains momentum with 112% growth in Korea and steady European uptake, highlighting global adoption despite regional headwinds.
Stryker Expands R&D Facility in India to Boost Medtech Innovation
SYK expands its Bangalore R&D hub to accelerate robotics, AI and digital health innovation while deepening ties with India's talent pool.
SNN vs. SYK: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of Smith & Nephew ( SNN Quick QuoteSNN - ) and Stryker ( SYK Quick QuoteSYK - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care
Stryker teams with Siemens Healthineers to develop a robotic ecosystem aimed at advancing stroke and aneurysm care.
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today - Stryker ( NYSE:SYK )
Stryker SYK has outperformed the market over the past 10 years by 1.48% on an annualized basis producing an average annual return of 14.52%. Currently, Stryker has a market capitalization of $146.02 billion.
SNN or SYK: Which Is the Better Value Stock Right Now?
SNN vs. SYK: Which Stock Is the Better Value Option?
Investing in the Age of Longevity: Silver Economy Stocks in Focus
AbbVie, Amgen, Stryker and Dexcom are tapping into the booming silver economy with new therapies, tech and acquisitions aimed at aging populations.
Has Akero Therapeutics ( AKRO ) Outpaced Other Medical Stocks This Year?
Here is how Akero Therapeutics, Inc. (AKRO) and Stryker (SYK) have performed compared to their sector so far this year.
Stryker's Robotics and Global Gains Offset by Macro Concerns
SYK posted strong Q2 growth driven by Mako robotics and global demand, but inflation, FX and competitive pressures temper near-term upside.
Stryker ( SYK ) Upgraded to Buy: What Does It Mean for the Stock?
Stryker (SYK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today - Stryker ( NYSE:SYK )
Stryker SYK has outperformed the market over the past 10 years by 1.86% on an annualized basis producing an average annual return of 14.02%. Currently, Stryker has a market capitalization of $145.32 billion.
SNN vs. SYK: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Smith & Nephew ( SNN Quick QuoteSNN - ) and Stryker ( SYK Quick QuoteSYK - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
ISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue?
Intuitive Surgical's Ion platform saw Q2 procedures jump 52% to 35,000, expanding globally as utilization rises despite softer system placements.
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RL, SYK, RGLD and ADSK hold promise.
J&J's MedTech Unit Sales Improve in Q2: Will the Upside Continue?
Johnson & Johnson's Q2 MedTech sales beat estimates, fueled by cardiovascular gains, surgical vision growth and new product momentum.
This Is What Whales Are Betting On Stryker - Stryker ( NYSE:SYK )
Whales with a lot of money to spend have taken a noticeably bullish stance on Stryker. Looking at options history for Stryker SYK we detected 8 trades. If we consider the specifics of each trade, it is accurate to state that 62% of the investors opened trades with bullish expectations and 12% ...
Tim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M Capital Infusion From Soleus Capital
BALTIMORE, Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- Longeviti Neuro Solutions, a neurotechnology company with a focus on innovative platform solutions for complex brain disorders, today announces the appointment of Tim Scannell, former President & COO of Stryker Corporation, as Chair of its Board of ...
Stryker ( SYK ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, July 31, 2025, at 4:30 p.m. ETFor a direct quote from a Motley Fool analyst, please email [email protected] reading ...
Are Medical Stocks Lagging Stryker ( SYK ) This Year?
Here is how Stryker (SYK) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
What's Driving the Market Sentiment Around Stryker? - Stryker ( NYSE:SYK )
Stryker's SYK short percent of float has fallen 17.09% since its last report. The company recently reported that it has 4.77 million shares sold short, which is 1.31% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.36 days to cover their ...
ISRG's Ion Platform Sees Uptick in Utilization, Eyes Efficiency
Intuitive Surgical's Ion platform posted 52% procedure growth in Q2, but rising system utilization and workflow efficiency now drive its profitability focus.
Stryker ( SYK ) Q2 Revenue Jumps 11%
Stryker ( NYSE:SYK ) , a leading global medical technology company, reported financial results on July 31, 2025. The company delivered several key beats: Net sales ( GAAP ) reached $6.0 billion, topping analyst expectations of $5.94 billion ( GAAP ) , and adjusted earnings per share ( non-GAAP ) ...
Stocks Sell Off, Gold Rallies On Tariff Turmoil, Weak Jobs Data: What's Moving Markets Friday? - Apple ( NASDAQ:AAPL )
It's a rough start to the new month for Wall Street, as major U.S. stock indices plunged by midday Friday, setting the stage for a negative weekly close. SPY ETF is breaking past support. Check the chart here.
SYK Stock Falls Despite Q2 Earnings & Sales Beat, '25 View Up
SYK's second-quarter results reflect strong segmental performance, along with a rise in operating margin.
Stryker ( SYK ) Q2 Earnings and Revenues Beat Estimates
Stryker (SYK) delivered earnings and revenue surprises of +2.29% and +1.09%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today - Stryker ( NYSE:SYK )
Stryker SYK has outperformed the market over the past 20 years by 2.17% on an annualized basis producing an average annual return of 10.71%. Currently, Stryker has a market capitalization of $153.44 billion.
What Does the Market Think About Stryker? - Stryker ( NYSE:SYK )
Stryker's SYK short percent of float has fallen 17.09% since its last report. The company recently reported that it has 4.77 million shares sold short, which is 1.31% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.36 days to cover their ...
GE HealthCare Technologies ( GEHC ) Q2 Earnings and Revenues Top Estimates
GE HealthCare (GEHC) delivered earnings and revenue surprises of +16.48% and +0.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Will SYK's Q2 Earnings Reflect Strong Growth Despite Tariff Overhang?
Stryker's second-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs and tariffs are likely to have continued to hurt margins.
SNN or SYK: Which Is the Better Value Stock Right Now?
SNN vs. SYK: Which Stock Is the Better Value Option?
A Look Into Stryker Inc's Price Over Earnings - Stryker ( NYSE:SYK )
In the current session, the stock is trading at $397.65, after a 0.25% increase. Over the past month, Stryker Inc. SYK stock increased by 2.28%, and in the past year, by 20.52%.
Stryker ( SYK ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ISRG vs. SYK: Which Robotic Surgery Stock Is the Stronger Buy Today?
Both are leaders in robotic-assisted surgery - Intuitive Surgical in soft tissue procedures and Stryker in orthopedic surgeries. Which company is a better bet now?
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today - Stryker ( NYSE:SYK )
Stryker SYK has outperformed the market over the past 10 years by 3.2% on an annualized basis producing an average annual return of 14.76%. Currently, Stryker has a market capitalization of $148.90 billion.
Rep. Thomas Kean Has Sold Up to $65K Worth Of Stryker Stock: Here's What You Should Know - Stryker ( NYSE:SYK ) , Prologis ( NYSE:PLD )
A July filing shows that Representative Thomas Kean reported a sale in Stryker SYK, valued between $16,002 and $65,000. The transaction date is listed as June 26, 2025, with the report published on July 16, 2025. At present, Stryker shares are trading down 0.0% at $390.87.
Hospital Capex Headwind: Temporary Setback or Lasting Risk for ISRG?
Intuitive Surgical's global da Vinci growth faces resistance as hospital CapEx tightens abroad, testing leasing and utilization strategies.
Looking Into Stryker's Recent Short Interest - Stryker ( NYSE:SYK )
Stryker's SYK short percent of float has risen 12.86% since its last report. The company recently reported that it has 5.74 million shares sold short, which is 1.58% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.84 days to cover their ...
Smart Money Going in Senior Health: Key Stocks in Elderly Care
RHHBY, NVO, EW and SYK are ramping up senior care innovation as aging populations reshape global healthcare demand.
ISRG Expands Installed Base, But Is Utilization Keeping Pace?
Intuitive Surgical's installed base tops 10,000, but flat utilization growth raises questions about ROI and system productivity.
HLN vs. SYK: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with Haleon PLC Sponsored ADR ( HLN Quick QuoteHLN - ) and Stryker ( SYK Quick QuoteSYK - ) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
Will J&J's Q2 Results Reflect End of MedTech Issues & Higher Sales?
JNJ's MedTech unit eyes second-half growth despite China headwinds, U.S. competition and tariff pressure.
ISRG da Vinci 5 Gets European Nod: Will it Boost the Stock's Prospect?
ISRG's da Vinci 5 wins CE mark, unlocking Europe's surgical robotics market as U.S. adoption shows strong early traction.
Here's How Much You Would Have Made Owning Stryker Stock In The Last 5 Years - Stryker ( NYSE:SYK )
Stryker SYK has outperformed the market over the past 5 years by 2.18% on an annualized basis producing an average annual return of 16.79%. Currently, Stryker has a market capitalization of $149.55 billion.
Patient Handling Equipment Market Lifts Off: Valued at US$18.98 Billion, Poised for Strong Growth | AnalystView Market Insights
San Francisco, USA, July 02, 2025 ( GLOBE NEWSWIRE ) -- The patient handling equipment market is witnessing robust growth, valued at USD 18,987.65 million in 2024 and projected to grow at a compound annual growth rate ( CAGR ) of 6.7% from 2024 to 2032.
SYK Boosts Foot & Ankle Portfolio With FDA-Cleared Total Ankle System
Stryker expands its Foot & Ankle portfolio with FDA-cleared InCompass, targeting streamlined total ankle replacement.
J&J's MedTech Segment Slowing Down: Will its Sales Recover in 2025?
JNJ's MedTech sales face pressure from China and competition but new products may lead to a stronger second half of 2025.
How Do Investors Really Feel About Stryker? - Stryker ( NYSE:SYK )
Stryker's SYK short percent of float has fallen 16.97% since its last report. The company recently reported that it has 4.98 million shares sold short, which is 1.37% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.02 days to cover their ...
